Diabetes Series Live

CME Speakers

Concentrated Insulins

  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Wendy S. Lane, MD

    Wendy S. Lane, MD

    Wendy S. Lane, MD

    Director of Clinical Research

    Wendy S. Lane, MD, is a clinical endocrinologist and director of clinical research at the Mountain Diabetes and Endocrine Center in Asheville, North Carolina. Dr Lane has served as principal investigator or sub-investigator for multiple clinical trials for new and investigational oral and injectable medications and insulins for the treatment of type 1 and type 2 diabetes, as well as glucose sensor and insulin pump trials. She has been an author and investigator for several investigator-initiated trials of U-500 insulin via insulin pump and trials involving combinations of GLP-1 receptor agonist therapy with insulin. She was also a contributing author to 2014 AACE Guidelines on Insulin Pump Therapy. Dr Lane earned her medical degree at Dartmouth Medical School in Hanover, New Hampshire.
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician, Medical Director, Professional Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.

Basal Insulin

  • Jason Gaglia, MD

    Jason Gaglia, MD

    Jason Gaglia, MD

    Director of Hood Center for the Prevention of Childhood Diabetes

    Jason Gaglia, MD, MMSc is Director of the Hood Center for Prevention of Childhood Diabetes at Joslin Diabetes Center and an Assistant Professor of Medicine at Harvard Medical School. He is a practicing adult endocrinologist at Joslin Clinic and Harvard Vanguard Medical Associates. Dr. Gaglia’s research interests include endocrine imaging and immunology of diabetes. He was previously a member of the clinical islet transplant team at the National Institute of Health. More recently he has led a team demonstrating noninvasive imaging of inflammation in the pancreas associated with the development of type 1 diabetes. Dr. Gaglia is an active member of the American Association of Clinical Endocrinologists (AACE). He is on the editorial board of Endocrine Practice, the official journal of AACE, and serves on several AACE committees.
  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician, Medical Director, Professional Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Mary Paschal, RN, MS, CDE

    Mary Paschal, RN, MS, CDE

    Mary Paschal, RN, MS, CDE

    Nurse Educator

    Mary Paschal, RN, MS, CDE, is registered nurse and certified diabetes educator at the Joslin Diabetes Center in Needham, Massachusetts. She specializes in diabetes self-management for adult patients with type 1 and type 2 diabetes, including insulin pump therapy and continuous glucose monitoring. She is the program manager responsible for maintaining a recognized certified educational program providing optimal outcomes for patients living with diabetes. Ms Paschal completed her undergraduate and graduate degrees at Boston College in Boston, Massachusetts.
  • Roger Decker

    Roger Decker

Cardiovascular Disease, Diabetes, and Diabetes Treatments

  • Donald E. Cutlip, MD

    Donald E. Cutlip, MD

    Donald E. Cutlip, MD

    Section Chief, Interventional Cardiology

    Donald E. Cutlip, MD, is section chief of interventional cardiology and director of the Cardiac Catheterization Laboratory at Beth Israel Deaconess Medical Center, professor of medicine at Harvard Medical School, and a senior investigator at the Baim Institute for Clinical Research in Boston, Massachusetts. His clinical activities focus on coronary and valvular interventions, with a special interest in cardiovascular disease in patients with diabetes. He is involved in the design and management of numerous clinical trials of coronary, valvular, and peripheral vascular interventions. Dr Cutlip founded the Academic Research Consortium, and was a member of the ACC/AHA Task Force’s writing committee for key data elements and definitions for cardiovascular endpoint events in clinical trials.
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician, Medical Director, Professional Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Vivian A. Fonseca, MD, FRCP

    Vivian A. Fonseca, MD, FRCP

    Vivian A. Fonseca, MD, FRCP

    Professor of Medicine and Pharmacology; Chief, Section of Endocrinology

    Vivian A. Fonseca, MD, FRCP, is a professor of medicine and pharmacology, the Tullis-Tulane Alumni Chair in Diabetes, and chief, Section of Endocrinology, at Tulane University Health Sciences Center in New Orleans, Louisiana. His current research interests include the prevention and treatment of diabetic complications and risk factor reduction in cardiovascular disease. Dr Fonseca is a fellow of the American Association of Clinical Endocrinologists, the Royal College of Physicians (London) and the American College of Physicians, and is a member of the Endocrine Society, the American Diabetes Association, and the International Diabetes Federation. He serves on numerous national and international committees, and has published more than 200 papers, review articles and book chapters.
  • Robert E. Heinig, MD

    Robert E. Heinig, MD

    Robert E. Heinig, MD

    Director, Vascular Disease Prevention Program

    Robert E. Heinig, MD, is clinical professor of medicine at the University of Rochester Medical School and director of the Vascular Diabetes Prevention Program at Rochester General Hospital in Rochester, New York. His current research interests include genetic and disease-related hyperlipidemia, normocholesterolemic dyslipidemia in insulin-resistant patients predisposing to coronary heart disease, and multiple risk factor modification in diabetic and insulin resistant patients with coronary heart disease. He belongs to several professional societies, including the American Diabetes Association, Endocrine Society, the American Society of Nephrology, and the American Association of Clinical Endocrinologists. Dr Heinig earned his MD from the University of Oregon School of Medicine in Portland.
  • Michael Rocco, MD

    Michael Rocco, MD

    Michael Rocco, MD

    Medical Director of Stress Testing and Cardiac Rehabilitation

    Michael Rocco, MD, is medical director of Cardiac Rehabilitation and Stress Testing, section of preventive cardiology, and a staff physician in the Departments of Cardiovascular Medicine and Molecular and Functional Imaging in the Division of Radiology at Cleveland Clinic in Ohio. His clinical research focuses primarily on the prognostic significance of asymptomatic ischemia, the evaluation of therapeutic interventions and exercise in the treatment and prevention of coronary artery disease, and the effect of drug therapy on lowering lipid levels. Dr Rocco lectures regionally and nationally, has published articles and abstracts in leading medical journals, and has authored chapters in textbooks. He received his medical degree from Duke University Medical Center in Durham, North Carolina.
  • Stephen A. Brunton, MD, FAAFP

    Stephen A. Brunton, MD, FAAFP

    Stephen A. Brunton, MD, FAAFP

    Executive Vice President

    Stephen Brunton, MD, FAAFP, is the executive vice president for education for the Primary Care Education Consortium, works in a group practice in Los Angeles, California, and is an adjunct clinical professor in the Department of Pharmacy Practice at Roseman University of Health Sciences in Salt Lake City, Utah. A board-certified family physician with a certificate of added qualifications in geriatrics, he earned his MD at Monash University Medical School in Melbourne, Australia. He is the former president of the California Academy of Family Physicians and the Association of Family Medicine Residency Directors. Dr Brunton has published numerous articles, chapters, and monographs on family medicine and related clinical topics, and serves in editorial capacities for numerous journals.
  • Om P. Ganda, MD

    Om P. Ganda, MD

    Om P. Ganda, MD

    Medical Director of the Lipid Clinic, Chair of the Clinical Oversight Committee

    Om P. Ganda, MD, FACE, is a board-certified specialist in internal medicine, endocrinology and metabolism, and clinical nutrition. He is a senior physician at the Joslin Diabetes Center and an associate professor of medicine at Harvard Medical School in Boston, Massachusetts. A co-investigator in the Diabetes Control and Complications Trial (DCCT), he has been engaged in clinical diabetes research for more than 3 decades. He is co-investigator of Epidemiology of Diabetes Interventions and Complications (EDIC), an ongoing, long-term, follow-up study. In addition to his clinical research and teaching, he directs the Lipid Clinic at Joslin, where he treats complex patients with dyslipidemia. Dr Ganda received his MD from the SMS Medical College, University of Rajasthan, Jaipur, India.

Joslin Diabetes Grand Rounds - Dyslipidemia and Diabetes

  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician, Medical Director, Professional Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Michael Rocco, MD

    Michael Rocco, MD

    Michael Rocco, MD

    Medical Director of Stress Testing and Cardiac Rehabilitation

    Michael Rocco, MD, is medical director of Cardiac Rehabilitation and Stress Testing, section of preventive cardiology, and a staff physician in the Departments of Cardiovascular Medicine and Molecular and Functional Imaging in the Division of Radiology at Cleveland Clinic in Ohio. His clinical research focuses primarily on the prognostic significance of asymptomatic ischemia, the evaluation of therapeutic interventions and exercise in the treatment and prevention of coronary artery disease, and the effect of drug therapy on lowering lipid levels. Dr Rocco lectures regionally and nationally, has published articles and abstracts in leading medical journals, and has authored chapters in textbooks. He received his medical degree from Duke University Medical Center in Durham, North Carolina.
  • Om P. Ganda, MD

    Om P. Ganda, MD

    Om P. Ganda, MD

    Medical Director of the Lipid Clinic, Chair of the Clinical Oversight Committee

    Om P. Ganda, MD, FACE, is a board-certified specialist in internal medicine, endocrinology and metabolism, and clinical nutrition. He is a senior physician at the Joslin Diabetes Center and an associate professor of medicine at Harvard Medical School in Boston, Massachusetts. A co-investigator in the Diabetes Control and Complications Trial (DCCT), he has been engaged in clinical diabetes research for more than 3 decades. He is co-investigator of Epidemiology of Diabetes Interventions and Complications (EDIC), an ongoing, long-term, follow-up study. In addition to his clinical research and teaching, he directs the Lipid Clinic at Joslin, where he treats complex patients with dyslipidemia. Dr Ganda received his MD from the SMS Medical College, University of Rajasthan, Jaipur, India.

All Speakers

  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Wendy S. Lane, MD

    Wendy S. Lane, MD

    Wendy S. Lane, MD

    Director of Clinical Research

    Wendy S. Lane, MD, is a clinical endocrinologist and director of clinical research at the Mountain Diabetes and Endocrine Center in Asheville, North Carolina. Dr Lane has served as principal investigator or sub-investigator for multiple clinical trials for new and investigational oral and injectable medications and insulins for the treatment of type 1 and type 2 diabetes, as well as glucose sensor and insulin pump trials. She has been an author and investigator for several investigator-initiated trials of U-500 insulin via insulin pump and trials involving combinations of GLP-1 receptor agonist therapy with insulin. She was also a contributing author to 2014 AACE Guidelines on Insulin Pump Therapy. Dr Lane earned her medical degree at Dartmouth Medical School in Hanover, New Hampshire.
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician, Medical Director, Professional Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Jason Gaglia, MD

    Jason Gaglia, MD

    Jason Gaglia, MD

    Director of Hood Center for the Prevention of Childhood Diabetes

    Jason Gaglia, MD, MMSc is Director of the Hood Center for Prevention of Childhood Diabetes at Joslin Diabetes Center and an Assistant Professor of Medicine at Harvard Medical School. He is a practicing adult endocrinologist at Joslin Clinic and Harvard Vanguard Medical Associates. Dr. Gaglia’s research interests include endocrine imaging and immunology of diabetes. He was previously a member of the clinical islet transplant team at the National Institute of Health. More recently he has led a team demonstrating noninvasive imaging of inflammation in the pancreas associated with the development of type 1 diabetes. Dr. Gaglia is an active member of the American Association of Clinical Endocrinologists (AACE). He is on the editorial board of Endocrine Practice, the official journal of AACE, and serves on several AACE committees.
  • Mary Paschal, RN, MS, CDE

    Mary Paschal, RN, MS, CDE

    Mary Paschal, RN, MS, CDE

    Nurse Educator

    Mary Paschal, RN, MS, CDE, is registered nurse and certified diabetes educator at the Joslin Diabetes Center in Needham, Massachusetts. She specializes in diabetes self-management for adult patients with type 1 and type 2 diabetes, including insulin pump therapy and continuous glucose monitoring. She is the program manager responsible for maintaining a recognized certified educational program providing optimal outcomes for patients living with diabetes. Ms Paschal completed her undergraduate and graduate degrees at Boston College in Boston, Massachusetts.
  • Roger Decker

    Roger Decker

  • Donald E. Cutlip, MD

    Donald E. Cutlip, MD

    Donald E. Cutlip, MD

    Section Chief, Interventional Cardiology

    Donald E. Cutlip, MD, is section chief of interventional cardiology and director of the Cardiac Catheterization Laboratory at Beth Israel Deaconess Medical Center, professor of medicine at Harvard Medical School, and a senior investigator at the Baim Institute for Clinical Research in Boston, Massachusetts. His clinical activities focus on coronary and valvular interventions, with a special interest in cardiovascular disease in patients with diabetes. He is involved in the design and management of numerous clinical trials of coronary, valvular, and peripheral vascular interventions. Dr Cutlip founded the Academic Research Consortium, and was a member of the ACC/AHA Task Force’s writing committee for key data elements and definitions for cardiovascular endpoint events in clinical trials.
  • Vivian A. Fonseca, MD, FRCP

    Vivian A. Fonseca, MD, FRCP

    Vivian A. Fonseca, MD, FRCP

    Professor of Medicine and Pharmacology; Chief, Section of Endocrinology

    Vivian A. Fonseca, MD, FRCP, is a professor of medicine and pharmacology, the Tullis-Tulane Alumni Chair in Diabetes, and chief, Section of Endocrinology, at Tulane University Health Sciences Center in New Orleans, Louisiana. His current research interests include the prevention and treatment of diabetic complications and risk factor reduction in cardiovascular disease. Dr Fonseca is a fellow of the American Association of Clinical Endocrinologists, the Royal College of Physicians (London) and the American College of Physicians, and is a member of the Endocrine Society, the American Diabetes Association, and the International Diabetes Federation. He serves on numerous national and international committees, and has published more than 200 papers, review articles and book chapters.
  • Robert E. Heinig, MD

    Robert E. Heinig, MD

    Robert E. Heinig, MD

    Director, Vascular Disease Prevention Program

    Robert E. Heinig, MD, is clinical professor of medicine at the University of Rochester Medical School and director of the Vascular Diabetes Prevention Program at Rochester General Hospital in Rochester, New York. His current research interests include genetic and disease-related hyperlipidemia, normocholesterolemic dyslipidemia in insulin-resistant patients predisposing to coronary heart disease, and multiple risk factor modification in diabetic and insulin resistant patients with coronary heart disease. He belongs to several professional societies, including the American Diabetes Association, Endocrine Society, the American Society of Nephrology, and the American Association of Clinical Endocrinologists. Dr Heinig earned his MD from the University of Oregon School of Medicine in Portland.
  • Michael Rocco, MD

    Michael Rocco, MD

    Michael Rocco, MD

    Medical Director of Stress Testing and Cardiac Rehabilitation

    Michael Rocco, MD, is medical director of Cardiac Rehabilitation and Stress Testing, section of preventive cardiology, and a staff physician in the Departments of Cardiovascular Medicine and Molecular and Functional Imaging in the Division of Radiology at Cleveland Clinic in Ohio. His clinical research focuses primarily on the prognostic significance of asymptomatic ischemia, the evaluation of therapeutic interventions and exercise in the treatment and prevention of coronary artery disease, and the effect of drug therapy on lowering lipid levels. Dr Rocco lectures regionally and nationally, has published articles and abstracts in leading medical journals, and has authored chapters in textbooks. He received his medical degree from Duke University Medical Center in Durham, North Carolina.
  • Stephen A. Brunton, MD, FAAFP

    Stephen A. Brunton, MD, FAAFP

    Stephen A. Brunton, MD, FAAFP

    Executive Vice President

    Stephen Brunton, MD, FAAFP, is the executive vice president for education for the Primary Care Education Consortium, works in a group practice in Los Angeles, California, and is an adjunct clinical professor in the Department of Pharmacy Practice at Roseman University of Health Sciences in Salt Lake City, Utah. A board-certified family physician with a certificate of added qualifications in geriatrics, he earned his MD at Monash University Medical School in Melbourne, Australia. He is the former president of the California Academy of Family Physicians and the Association of Family Medicine Residency Directors. Dr Brunton has published numerous articles, chapters, and monographs on family medicine and related clinical topics, and serves in editorial capacities for numerous journals.
  • Om P. Ganda, MD

    Om P. Ganda, MD

    Om P. Ganda, MD

    Medical Director of the Lipid Clinic, Chair of the Clinical Oversight Committee

    Om P. Ganda, MD, FACE, is a board-certified specialist in internal medicine, endocrinology and metabolism, and clinical nutrition. He is a senior physician at the Joslin Diabetes Center and an associate professor of medicine at Harvard Medical School in Boston, Massachusetts. A co-investigator in the Diabetes Control and Complications Trial (DCCT), he has been engaged in clinical diabetes research for more than 3 decades. He is co-investigator of Epidemiology of Diabetes Interventions and Complications (EDIC), an ongoing, long-term, follow-up study. In addition to his clinical research and teaching, he directs the Lipid Clinic at Joslin, where he treats complex patients with dyslipidemia. Dr Ganda received his MD from the SMS Medical College, University of Rajasthan, Jaipur, India.